Comparison between cryotherapy and radiofrequency energy sources for parahisian accessory pathway percutaneous ablation.

BACKGROUND: Catheter ablation of parahisian accessory pathways (PHAP) are challenging due to their proximity to the normal conduction system. Retrospective studies suggest that cryoablation has a better safety profile but a higher recurrence rate when compared to radiofrequency ablation (RFCA). The objective of this study was to compare the results of parahisian AP ablation performed by electrophysiologists with experience in both technologies. METHODS: Prospective single-center, non-blinded and 1:1 model was used. Patients included had parahisian AP confirmed by an electrophysiological study and referred for radiofrequency or cryotherapy ablation according to current guidelines, under fluoroscopic guidance. No electroanatomic mapping was used. RESULTS: A total of 30 patients (mean age of 25±9.4 years; 90% male) were enrolled between Oct/2018 to Feb/2020. Acute success rate between RFCA and CRYO were similar (93% vs. 87%, p = 0.54). A nonsignificant reduction in short-term recurrence rate for RFCA (14% vs. 30%, p = 0.3) and mechanical trauma (6% vs. 20%; p = 0.28) was observed. Long-term recurrence rate and event-free survival time were similar in both groups after 1-year follow-up (p = 0.286). No persistent complete AV block or conduction disturbance was also observed. CONCLUSION: Considering the limitation of a small sample size and the lack of use of electroanatomic mapping for RFCA, the efficacy and safety profile of parahisian AP ablation with RFCA was not different from CRYO, when performed by experienced electrophysiologists. No cases of permanent complete AV block were reported with either energy modalities.

Would a complete electrophysiological study allow us to make a correct diagnosis? Case report.

BACKGROUND: Oblique course of some left accessory pathways is rare An incomplete electrophysiological study may confuse us between an oblique accessory pathway or the presence of two accessory pathways. The proximity of all atrial and ventricular electrograms, at each pole of the catheter, within the coronary sinus may be a novel finding. CASE PRESENTATION: A 68-year-old woman patient presented arrhythmias with hypotension requiring electrical cardioversion. Her electrocardiogram (ECG) was interpreted as atrial fibrillation by accessory pathway. We performed with the protocol of ablation stablished in our laboratory: two punctures on the right femoral vein with placement of introducers (8F and 7F) by Seldigner technique and one puncture on the left femoral vein (7F). The study was performed with BIOTRONIK technology (Multicath study catheter), a non-deflectable 7F quadripolar catheter with 2 mm tip electrode to record the His electrogram, a non-deflectable decapolar catheter with 5 pairs of coronary sinus (CS) electrodes. Accessory pathway mapping was performed in right and left cavities and within the CS. All electrograms into CS showed short AV from proximal to distal CS. Finally, ablation of two accessory pathway recordings was achieved at two distant epicardial points within the CS. CONCLUSIONS: Ablation at two distant sites, one on the ventricular side and the other on the mitral annulus, suggests the presence of an oblique accessory pathway and at the same time the differential diagnosis of the presence of two accessory pathways. In our point of view according the above, we consider this is a very rare case of oblique AP with epicardial trajectory. The sequence of electrograms (in this case) along the CS has not been seen before in the literature reviewed. It is important, regardless of the urgency, to follow diagnostic and therapeutic protocols in invasive electrophysiology.

Variability of the VA interval at tachycardia induction: a simple method to differentiate orthodromic reciprocating tachycardia from atypical atrioventricular nodal reentrant tachycardia.

BACKGROUND: The differential diagnosis between orthodromic atrioventricular reentry tachycardia (AVRT) and atypical AV nodal reentrant tachycardia (aAVNRT) is sometimes challenging. We hypothesize that aAVNRTs have more variability in the retrograde conduction time at tachycardia onset than AVRTs. METHODS: We aimed to assess the variability in retrograde conduction time at tachycardia onset in AVRT and aAVNRT and to propose a new diagnostic tool to differentiate these two arrhythmia mechanisms. We measured the VA interval of the first beats after tachycardia induction until it stabilized. The difference between the maximum and minimum VA intervals (∆VA) and the number of beats needed for the VA interval to stabilize was analyzed. Atrial tachycardias were excluded. RESULTS: A total of 107 patients with aAVNRT (n = 37) or AVRT (n = 64) were included. Six additional patients with decremental accessory pathway-mediated tachycardia (DAPT) were analyzed separately. All aAVNRTs had VA interval variability. The median ∆VA was 0 (0 - 5) ms in AVRTs vs 40 (21 - 55) ms in aAVNRTs (p < 0.001). The VA interval stabilized significantly earlier in AVRTs (median 1.5 [1 - 3] beats) than in aAVNRTs (5 [4 - 7] beats; p < 0.001). A ∆VA < 10 ms accurately differentiated AVRT from aAVNRT with 100% of sensitivity, specificity, and positive and negative predictive values. The stabilization of the VA interval at < 3 beats of the tachycardia onset identified AVRT with sensitivity, specificity, and positive and negative predictive values of 64.1%, 94.6%, 95.3%, and 60.3%, respectively. A ∆VA < 20 ms yielded good diagnostic accuracy for DAPT. CONCLUSIONS: A ∆VA < 10 ms is a simple and useful criterion that accurately distinguished AVRT from atypical AVNRT. Central panel: Scatter plot showing individual values of ∆VA in atypical AVNRT and AVRT. Left panel: induction of atypical AVNRT. The VA interval stabilizes at the 5th beat and the ∆VA is 62 ms (maximum VA interval: 172 ms - minimum VA interval: 110 ms). Right panel: induction of AVRT. The tachycardia has a fixed VA interval from the first beat. ∆VA is 0 ms.

Use of contact force technology for cardiac arrhythmia ablation in children.

Background: New techniques for cardiac arrhythmia ablation, such as contact force (CF) technology, have emerged recently. These catheters provide information about adequate tissue contact for optimal lesions. In adults, these techniques have shown greater accuracy, reduced arrhythmia recurrence and complications, and higher success rates. However, data on pediatric patients are limited. Objective: The purpose of this study was to describe the experience with arrhythmia ablation using CF catheters in the pediatric population. Methods: A retrospective cross-sectional descriptive study of all patients <18 years old undergoing cardiac 3-dimensional mapping and ablation with CF between March 2016 and June 2022 was performed. Results: A total of 321 patients were included (51.40% male; mean age 12.26 years). The most frequent arrhythmia were supraventricular tachycardia (SVT) mediated by accessory pathways (APs) (atrioventricular reentrant tachycardia in 82.24%, ventricular arrhythmia in 11.21%, atrial tachycardia in 5.92%). Mean procedural time was 2.86 ± 1.2 hours, and average contact used was 14.33g ± 6.88g. The success rate of ablation was 97.82% with a low risk of complications. Conclusion: This is the largest published series of CF technology use in patients <18 years old. In the pediatric population, CF ablation is a safe procedure with high success rates and can be used for most arrhythmic substrates. The most frequent tachycardia observed in this study was SVT mediated by APs. Contact with 14g is safe and yields an excellent outcome in children. The presence of structural heart anomalies and previous ablation procedures decreased the success rate.

Anomalía de Ebstein y aneurisma del seno coronario / Ebstein’s anomaly and coronary sinus aneurysm

Resumen La anomalía de Ebstein es una cardiopatía congénita poco común que se asocia a la presencia de vías de conducción anómalas y episodios de taquicardia supraventricular frecuentes, algunos inestables. La asociación con alteraciones anatómicas del seno coronario es rara y no ha sido reportada. Se presenta el caso de una paciente de 58 años con enfermedad coronaria, anomalía de Ebstein, episodios de taquicardia ortodrómica y aneurisma del seno coronario, a quien se realizó ablación.

Abstract Ebstein’s disease is a congenital cardiomyopathy, with a low prevalence in the general population. This abnormality has been associated with abnormal cardiac conduction problems, one of the most important being the accessory pathways. In the presence of an accessory pathway, frequent supraventricular tachycardias may occur, some of which are poorly tolerated. The association with the anomalies of the coronary sinus is not currently reported. The case of a 58-year-old woman with Ebstein’s disease, episodes of supraventricular tachycardia, and coronary sinus aneurysm undergoing ablation therapy is presented.

Management of Asymptomatic Wolff-Parkinson-White Pattern by Pediatric Electrophysiologists.

OBJECTIVE: To determine the present-day approach of pediatric cardiac electrophysiologists to asymptomatic Wolff-Parkinson-White (WPW) pattern and to contrast to both published consensus statements and a similar survey. STUDY DESIGN: A questionnaire was sent to 266 Pediatric and Congenital Electrophysiology Society physician members in 25 countries; 21 questions from the 2003 survey were repeated, with new questions added regarding risk stratification and decision making. RESULTS: We received 113 responses from 13 countries, with responders having extensive electrophysiology experience (median 15 years [IQR 8.5-25 years]). Only 12 (11%) believed that intermittent pre-excitation and 37 (33%) that sudden loss of pre-excitation on exercise test were sufficient evidence of accessory pathway safety to avoid an invasive electrophysiology study. Optimal weight for electrophysiology study was 20 kg (IQR 18-22.5 kg), and 61% and 58% would then ablate all right-sided or left-sided accessory pathways, respectively, regardless of electrophysiological properties, whereas only 23% would ablate all septal accessory pathways (P < .001). Compared with 2003, respondents were more likely to consider inducible arrhythmia (77% vs 26%, P < .001) as sufficient indication alone for ablation. CONCLUSIONS: In the context of recent literature regarding the reliability of risk-stratification tools, most operators are now performing electrophysiology study for asymptomatic Wolff-Parkinson-White regardless of noninvasive findings. Many will then proceed to default ablation of all accessory pathways distant from critical conduction structures.

Percutaneous Catheter Ablation of Epicardial Accessory Pathways.

Radiofrequency (RF) catheter ablation is the treatment of choice in patients with accessory pathways (APs) and Wolff-Parkinson-White syndrome. Endocardial catheter ablation has limitations, including the inability to map and ablate intramural or subepicardial APs. Some of these difficulties can be overcome using an epicardial approach performed through the epicardial venous system or by percutaneous catheterisation of the pericardial space. When a suspected left inferior or infero-paraseptal AP is refractory to ablation or no early activation is found at the endocardium, a transvenous approach via the coronary sinus is warranted because such epicardial pathways can be in close proximity to the coronary venous system. Associated congenital abnormalities, such as right atrial appendage, right ventricle diverticulum, coronary sinus diverticulum and absence of coronary sinus ostium, may also hamper a successful outcome. Percutaneous epicardial subxiphoid approach should be considered when endocardial or transvenous mapping and ablation fails. Epicardial mapping may be successful. It can guide and enhance the effectiveness of endocardial ablation. The finding of no epicardial early activation leads to a more persistent new endocardial attempt. When both endocardial and epicardial ablation are unsuccessful, open-chest surgery is the only option to eliminate the AP.

Dos décadas de seguimiento exitoso de la primera ablación de arritmias por catéter de radiofrecuencia realizado en la historia de la medicina del Paraguay / Two decades of succesful follow-up of the first radiofrequency catheter arrhythmia ablation done in the history of medicine in Paraguay

La técnica de mapeo endocárdico durante el estudio electrofisiológico ha sido extensamente empleada en el análisis de las taquicardias paroxísticas supraventriculares (TPS). Mediante este mapeo endocárdico y el análisis meticuloso de los electrogramas endocárdicos y los respectivos intervalos de conducción, es posible localizar el sitio de origen de las arritmias y así facilitar su tratamiento ablativo por medio de catéteres de radiofrecuencia. Se describe el caso de un hombre de 29 años con síndrome de Wolff-Parkinson-White (WPW) que manifiestó que presentaba varios episodios documentados de TPS con serio compromiso hemodinámico que motivaba su frecuente internación en terapia intensiva. El mapeo electrofisiológico endocárdico meticuloso demostró la presencia de un haz anómalo de Kent auriculoventricular izquierdo en posición posteroseptal. El período refractario absoluto del haz anómalo de Kent fue de 240 ms. La primera emisión de radiofrecuencia a través de un catéter adecuadamente posicionado previo terminó la taquicardia. La taquicardia permaneció no inducible a partir de entonces. En estas dos décadas de seguimiento clínico, el paciente no ha presentado ni un solo episodio de taquicardia. La curación definitiva generada por la ablación del haz anómalo de Kent ha proporcionado un cambio drástico, total y beneficioso en la calidad de vida al paciente. Los beneficios clínicos y socioeconómicos son mayores cuanto más temprano en la evolución se realice el procedimiento de ablación de arritmias.

Endocardial mapping has been widely used for the analysis of supraventriculartachycardias during electrophysiological study. This mapping and the detailed analysis ofendocardial electrograms and conduction intervals allow for the localization of the site oforigin of the arrhythmias thus facilitating curative treatment with radiofrequency catheterablation. The case describes our 29 years old patient with manifested Wolff-ParkinsonWhitesyndrome that presented frequent, documented episodes of paroxysmal supraventricular tachycardia with serious hemodynamic alteration that needed frequentadmissions to intensive care units despite the use of 2-3 antiarrhythmic agents per day. Adetailed endocardial mapping showed a left posteroseptal accessory pathway. Theaccessory pathway effective refractory period is 240 ms. The first radiofrequency emissionthrough an adequately positioned radiofrequency catheter terminated the tachycardia. Thetachycardia was rendered non-inducible thereafter. In two decades of follow-up, the patienthas not presented a single episode of tachycardia. The definite cure provided by theradiofrequency ablation produced a total, dramatic, and beneficial change in the quality oflife of the patient. The clinical and socio-economical benefits are greater the earlier thearrhythmia ablation procedure is performed.

La electrofisiología del Wolff-Parkinson-White en el paciente asintomático con actividad o riesgo profesional alto / The electrophysiology of Wolff-Parkinson-White in the asymptomatic patient with activity or with high professional risk

Objetivo: Describir las características electrofisiológicas en individuos con Wolff-Parkinson-White asintomático con actividad deportiva o alta responsabilidad profesional. Métodos: Se evaluaron 19 individuos, edad media 33 ± 13 años (grupo A). Las características electrofisiológicas fueron comparadas con un grupo control similar con WPW sintomático (grupo B). Resultados: En estado basal el periodo refractario anterógrado y la conducción anterógrada 1:1 sobre el fascículo accesorio fueron más largos en el grupo A (300 ± 48 ms vs 262 ± 32 ms, p < 0.05) y (355 ± 108 ms vs 307 ± 86 ms, p < 0.05), respectivamente. Ningún individuo del grupo A tuvo un periodo refractario anterógrado < 250 ms; y 58% no tuvieron conducción retrógrada sobre el fascículo accesorio vs 4% del grupo B (p< 0.001). La inducción de taquicardia fue significativamente menor (5.2%) en el grupo A vs grupo B (95%) (p < 0.001). Se indujo fibrilación auricular (FA) sólo en uno del grupo A vs en 32% grupo B (p< 0.001). Conclusión: Se confirman las características electrofisiológicas benignas en individuos asintomáticos comparados con sintomáticos. La deficiente conducción anterógrada junto con ausencia de conducción retrógrada explica la baja frecuencia de taquiarritmias y no apoyaría la investigación rutinaria en toda la población asintomática, pero debido a las posibles consecuencias, se mantiene la indicación sistemática con fines de ablación preventiva en el subgrupo de individuos asintomáticos con actividad deportiva o alta responsabilidad profesional.

Objective: Describe the electrophysiological characteristics in subjects with asymptomatic Wolff-Parkinson-White with sports activities or high professional responsibility. Methods: Nineteen subjects, mean age 33 ± 13 years (group A). The electrophysiological characteristics were compared with a matched group with symptomatic WPW (group B). Results: At baseline the anterograde refractory period and the anterograde conduction 1:1 over the accessory pathway were longer in group A (300 ± 48 ms vs 262 ± 32 ms, p <0.05 and 355 ± 108 ms vs 307 ± 86 ms, p <0.05), respectively. None of group A had a anterograde refractory period < 250 ms and 58% showed absence of retrograde conduction over the accessory pathway vs 4% of group B (p < 0.001). Induction of tachycardia was significantly less in group A (5%) than in group B (92%) (p < 0.001). Atrial fibrillation was induced in only one of group A vs 32% of group B (p< 0.001). Conclusion: We confirm the benign electrophysiological characteristics in asymptomatic compared to symptomatic subjects. Poor anterograde conduction along with absence of retrograde conduction explains the low frequency of tachyarrhythmias and would not support the routine investigation of all asymptomatic subjects. But, due to possible consequences, remains the systematic indication for preventive ablation in the subgroup of asymptomatic subjects with sporting activities or high professional responsibility.

Antegrade or retrograde accessory pathway conduction: who dies first?

A 36 year-old man with Wolff Parkinson White syndrome due to a left-sided accessory pathway (AP) was referred for catheter ablation. Whether abolition of antegrade and retrograde AP conduction during ablation therapy occurs simultaneously, is unclear. At the ablation procedure, radiofrequency delivery resulted in loss of preexcitation followed by a short run of orthodromic tachycardia with eccentric atrial activation, demonstrating persistence of retrograde conduction over the AP after abolition of its antegrade conduction. During continued radiofrequency delivery at the same position, the fifth non-preexcitated beat failed to conduct retrogradely and the tachycardia ended. In this case, antegrade AP conduction was abolished earlier than retrograde conduction.

Ablación transquirúrgica de vía accesoria atrioventricular en anomalía de Ebstein / Surgical radioerequency catheter ablation of accessory pathways in Ebstein's anomaly

Fueron estudiados 13 pacientes con anomalía de Ebstein con taquicardia por reentrada atrioventricular y al menos una vía accesoria. En 7 pacientes (53.8%) existía una vía accesoria y en 6 pacientes (46.1%) vías múltiples. En 5 pacientes (38.4%) se encontró vía accesoria tipo Mahaim. Un total de 22 vías accesorias fueron identificadas de las cuales 2 (9%) eran ocultas. El 100% se localizaron en el anillo tricuspídeo. Los sitios más frecuentes de ubicación fueron: región lateral derecha con 11 (50%) y postero-septal derecha con 5 (22.7%). Diez pacientes recibieron tratamiento mediante ablación con radiofrecuencia vía transquirúrgica y tres mediante sección quirúrgica. Se obtuvo un éxito de 100%. No se presentaron complicaciones durante los procedimientos. Conclusión: La ablación transquirúrgica de vías accesorias atrioventriculares en pacientes con anomalía de Ebstein es un procedimiento seguro y eficaz.

Thirteen patients with Ebstein anomaly and atrioventricular reentrant tachycardia and at least one accessory pathway were included in this study. One accessory pathway in 7 (53.8%) patients and multiple accessory pathways in 6 (46.1%) were found. Mahaim accessory pathway was observed in 5 (38.4%) patients. A total of 22 accessory pathways was found, 2 (9%) were concealed. In all (100%), the accessory pathways were located in the tricuspid ring. The most frequent regions were right lateral free wall with 11 (50%) and 5 right posteroseptal (22.7%). Ten patients underwent surgical radiofrequency catheter ablation and three subjected to surgical section. We obtained success in 100%. No complications were observed during the procedures. In conclusion, surgical ablation therapy in patients with accessory pathways and Ebstein's anomaly is safe and effective.

Seguimiento a largo plazo en 413 pacientes con vía accesoria atrioventricular sometidos a ablación con radiofrecuencia

Objetivo: se analizan los resultados clínicos y el seguimiento a largo plazo de los pacientes que fueron sometidos a ablación endocárdica mediante radiofrecuencia para el tratamiento de la taquicardia paroxística supraventricular por vía accesoria atrioventricular. Material y métodos: se incluyeron 413 pacientes a quienes se les realizó ablación con radiofrecuencia de vías accesorias atrioventricular de abril de 1992 a diciembre de 1995. Resultados: de los 413 pacientes seleccionados, 234 (57%) eran hombres y 179 (43%) eran mujeres, con edad promedio de 31.3 ± 16.3 años (límites 2 a 69 años). Se localizó un total de 437 vías accesorias atrioventriculares, 389 (93)% eran únicas y en 24 enfermos estuvieron presentes dos vías accesorias. La ablación tuvo éxito inmediato en 381 vías atrioventriculares (87%), durante el seguimiento promedio de siete años, se observó recurrencia de 51 vías atrioventriculares (13%), de estas 41 (80%) recurrieron en los primeros tres meses. A cincuenta y seis pacientes se les realizó una segunda sesión de ablación, con éxito de 35 (62.5%) y nueva recurrencia en 2 (5.7%). Son 365 vías accesorias (83.5) que permanecen sin recurrencia de taquicardia o preexcitación. Conclusiones: durante el seguimiento, los efectos de la ablación exitosa con RF se preservan en el tiempo. La taquicardia identificada en recurrencia siempre correspondió al mecanismo de reentrada a través de la vía accesoria.

Objective: the aim of this study was shown clinical characteristics and follow-up of patients with atrioventricular reentrant tachycardia (AVRT) who underwent radiofrequency catheter ablation (RCA) therapy. Material and Methods: from April 1992 to December 1995, 413 patients with AVRT underwent RCA therapy. Results: two hundred thirty four men (57%) and one hundred seventy nine women (43%) aged 31.3 ± 16-3 years were studied. 437 single accessory pathways were found; 24 had multiple accessory pathways. Ablation therapy was successful in 381 accessory pathways. During follow-up of 7 years, AVRT recurred in 51 patients (13%) and in 80% this occurred within the first 3 months after the procedure. 56 patients underwent a second RCA therapy with success in 35 patients (83.5); two reoccurred (5.7%); 365 accessory pathways (83.5) remained without evidence of preexcitation AVRT. Conclusions: during follow-up, these patients with successful ablation therapy remained without symptoms. In patients who underwent a second RCA therapy, atrioventricular reentrant mechanism was always present.

Fulguraçäo endocavitária de vias acessórias no tratamento da síndrome de Wolff-Parkinson-White / Endocavitary fulguration of accessory pathways in the treatment of Wolff-Parkinson-White syndrome

Apresentar nossa experiência inicial no tratamento definitivo da síndrome de Wolff-Parkinson-White, através de fulguraçäo endocavitária de vias acessórias. Quatorze sessöes de fulguraçäo endocavitária realizadas em 9 portadores de síndrome de Wolff-Parkinson-White. Cinco eram do sexo masculino e a média de idade foi de 35 anos. Obteve-se completa interrupçäo da conduçäo pela via anômala em 7 pacientes: 4 através de uma e 3 de duas sessöes. Um paciente (1§ da série) foi submetido a três sessöes, näo se conseguindo a interrupçäo definitiva da conduçäo pela via acessória, e encaminhado a cirurgia. O restante, näo responsivo à primeira tentativa, aguarda nova sessäo. Näo foram observadas complicaçöes cardiológicas inerentes ao procedimento. A fulguraçäo endocavitária de vias acessórias mostrou-se método seguro, eficaz e portanto passível de ser cogitado como primeira opçäo quando da indicaçäo de ablaçäo desses feixes anômalos